Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof
US10597391B2 · kind B2 · utility
1Cited by
9References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2017 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Oct 25, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula I, Pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.